# Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus

> **NCT04037514** · PHASE3 · COMPLETED · sponsor: **Máximo Vento Torres** · enrollment: 133 (actual)

## Conditions studied

- Patent Ductus Arteriosus After Premature Birth

## Interventions

- **DRUG:** Paracetamol
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT04037514
- **Lead sponsor:** Máximo Vento Torres
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-07
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04037514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04037514, "Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04037514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*